| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 25, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 39,800 | $6.41 | $255,170.00 | - | |
| Jul 24, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 45,000 | $6.42 | $289,049.50 | - | |
| Jul 24, 2017 | CDNA Caredx, Inc. | Gagnon Neil | 10% Owner | Buy | 1,486 | $1.23 | $1,827.78 | +0.2% | |
| Jul 21, 2017 | DHR Danaher Corp /de/ | Hefner Linda P58 | Director | Sell | 10,578 | $83.03 | $878,238.45 | -25.1% | |
| Jul 21, 2017 | DHR Danaher Corp /de/ | King William | Senior Vice President | Sell | 7,458 | $82.96 | $618,752.97 | -29.0% | |
| Jul 20, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 5,400 | $6.46 | $34,871.50 | - | |
| Jul 17, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $6.04 | $10,871.00 | - | |
| Jul 17, 2017 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 3,830 | $100.81 | $386,103.39 | -0.8% | |
| Jul 17, 2017 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 200 | $101.38 | $20,276.00 | -0.7% | |
| Jul 14, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 12,600 | $6.16 | $77,563.50 | - | |
| Jul 13, 2017 | A Agilent Technologies, Inc. | Kaltenbach Patrick | Sr Vice President | Sell | 5,000 | $61.26 | $306,300.00 | -11.1% | |
| Jul 12, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,600 | $6.12 | $22,049.50 | - | |
| Jul 10, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,264 | $99.07 | $917,818.19 | -0.1% | |
| Jul 10, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 5,720 | $99.30 | $568,010.96 | - | |
| Jul 10, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 9,516 | $98.92 | $941,337.01 | -0.1% | |
| Jul 10, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 50,000 | $6.19 | $309,570.13 | - | |
| Jul 10, 2017 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 500 | $100.02 | $50,007.50 | - | |
| Jul 6, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 25,000 | $6.29 | $157,141.39 | - | |
| Jul 3, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 60,800 | $6.44 | $391,396.25 | - | |
| Jul 3, 2017 | EXAS Exact Sciences Corp | Coward D Scott77 | SVP And General Counsel | Sell | 1,987 | $35.21 | $69,962.27 | -3.2% | |
| Jun 30, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 3,600 | $6.58 | $23,699.50 | - | |
| Jun 29, 2017 | CDNA Caredx, Inc. | Gagnon Neil | 10% Owner | Buy | 1,808 | $1.11 | $2,006.88 | +0.2% | |
| Jun 28, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $6.87 | $12,366.00 | - | |
| Jun 27, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 21,800 | $6.77 | $147,540.50 | - | |
| Jun 26, 2017 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 1,800 | $6.97 | $12,543.30 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.